World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
58
Citations
14754
World Ranking
2071
National Ranking
165

Yuki Yamaguchi publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Yuki Yamaguchi sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 147 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Yuki Yamaguchi D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Yuki Yamaguchi sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Yuki Yamaguchi is affiliated with the Tokyo Institute of Technology in Japan and has contributed extensively to research in biochemistry, genetics, molecular biology, and medicine. Their work spans multiple subfields, primarily focusing on molecular biology, oncology, genetics, materials chemistry, and surgery.

The scientist's research covers key topics including RNA modifications and cancer, RNA research and splicing, epigenetics and DNA methylation, protein degradation and inhibitors, multiple myeloma research and treatments, genomics and chromatin dynamics, and ubiquitin and proteasome pathways.

Yamaguchi's recent publications include the following papers:

  • Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders, 2022, Chemical Society Reviews
  • ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells, 2020, Nature Chemical Biology
  • Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology, 2021, Cell Chemical Biology
  • Genome-wide screening reveals a role for subcellular localization of CRBN in the anti-myeloma activity of pomalidomide, 2020, Scientific Reports
  • The role of Mediator and Little Elongation Complex in transcription termination, 2020, Nature Communications

The frequent co-authors collaborating with Yamaguchi include:

  • Kiyoshi Misawa
  • Daiki Mochizuki
  • Hiroyuki Mineta
  • Ryuji Ishikawa
  • Seiji Hosokawa

Yamaguchi's work has been published in a variety of venues, with notable recurrent appearances in:

  • Practica oto-rhino-laryngologica Suppl
  • Scientific Reports
  • Nature Communications
  • Biological and Pharmaceutical Bulletin
  • Research Square

Best Publications

  • Identification of a Primary Target of Thalidomide Teratogenicity

    Takumi Ito;Hideki Ando;Takayuki Suzuki;Toshihiko Ogura

  • NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation

    Yuki Yamaguchi;Toshiyuki Takagi;Tadashi Wada;Keiichi Yano

  • DSIF, A NOVEL TRANSCRIPTION ELONGATION FACTOR THAT REGULATES RNA POLYMERASE II PROCESSIVITY, IS COMPOSED OF HUMAN SPT4 AND SPT5 HOMOLOGS

    Tadashi Wada;Toshiyuki Takagi;Yuki Yamaguchi;Anwarul Ferdous

  • EVIDENCE THAT P-TEFB ALLEVIATES THE NEGATIVE EFFECT OF DSIF ON RNA POLYMERASE II-DEPENDENT TRANSCRIPTION IN VITRO

    Tadashi Wada;Toshiyuki Takagi;Yuki Yamaguchi;Daisuke Watanabe

  • P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation.

    Tomoko Yamada;Yuki Yamaguchi;Yuki Yamaguchi;Naoto Inukai;Sachiko Okamoto

  • NELF and DSIF cause promoter proximal pausing on the hsp70 promoter in Drosophila

    Chwen Huey Wu;Yuki Yamaguchi;Lawrence R. Benjamin;Maria Horvat-Gordon

  • Mutations of the PAX6 Gene Detected in Patients with a Variety of Optic-Nerve Malformations

    Noriyuki Azuma;Yuki Yamaguchi;Hiroshi Handa;Keiko Tadokoro

  • Evidence that Negative Elongation Factor Represses Transcription Elongation through Binding to a DRB Sensitivity-Inducing Factor/RNA Polymerase II Complex and RNA

    Yuki Yamaguchi;Naoto Inukai;Takashi Narita;Tadashi Wada

  • Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex.

    Takashi Narita;Yuki Yamaguchi;Keiichi Yano;Seiji Sugimoto

  • Mediator requirement for both recruitment and postrecruitment steps in transcription initiation.

    Gang Wang;Michael A. Balamotis;Jennitte L. Stevens;Yuki Yamaguchi

  • Spatial Redox Regulation of a Critical Cysteine Residue of NF-κB in Vivo

    Takeyuki Nishi;Noriaki Shimizu;Masaki Hiramoto;Iwao Sato

  • NELF interacts with CBC and participates in 3' end processing of replication-dependent histone mRNAs.

    Takashi Narita;Tetsu M.C. Yung;Junichi Yamamoto;Yasunori Tsuboi

  • A highly purified RNA polymerase II elongation control system.

    Dan B. Renner;Yuki Yamaguchi;Tadashi Wada;Hiroshi Handa

  • Stimulation of RNA polymerase II elongation by hepatitis delta antigen.

    Yuki Yamaguchi;Julija Filipovska;Keiichi Yano;Akiko Furuya

  • Transcription elongation factors DSIF and NELF: promoter-proximal pausing and beyond.

    Yuki Yamaguchi;Hirotaka Shibata;Hiroshi Handa

  • Structure and function of the human transcription elongation factor DSIF.

    Yuki Yamaguchi;Tadashi Wada;Daisuke Watanabe;Toshiyuki Takagi

  • Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance

    Yasuaki Kabe;Takanori Nakane;Ikko Koike;Tatsuya Yamamoto

  • A regulator of transcriptional elongation controls vertebrate neuronal development

    Su Guo;Yuki Yamaguchi;Sarah Schilbach;Tadashi Wada

  • A new APE1/Ref-1-dependent pathway leading to reduction of NF-κB and AP-1, and activation of their DNA-binding activity

    Kozue Ando;Satoshi Hirao;Yasuaki Kabe;Yuji Ogura

  • Missense Mutation in the Alternative Splice Region of the PAX6 Gene in Eye Anomalies

    Noriyuki Azuma;Yuki Yamaguchi;Hiroshi Handa;Mutsuko Hayakawa

Frequent Co-Authors

Hiroshi Handa
Hiroshi Handa Tokyo Medical University
Hajime Watanabe
Hajime Watanabe Osaka University
Makoto Suematsu
Makoto Suematsu Keio University
Joan Weliky Conaway
Joan Weliky Conaway The University of Texas Southwestern Medical Center
Arnold J. Berk
Arnold J. Berk University of California, Los Angeles
Ronald C. Conaway
Ronald C. Conaway The University of Texas Southwestern Medical Center
Hisao Ishii
Hisao Ishii Chiba University
Jun-ichi Sawada
Jun-ichi Sawada University of Shizuoka
Shigetsugu Hatakeyama
Shigetsugu Hatakeyama Hokkaido University
Masato Nakafuku
Masato Nakafuku Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to diverse online degree options and career paths in science, healthcare, and education. For those seeking flexible studies at reputable schools, many non profit colleges offer robust online science programs designed for academic rigor and long-term value.

If you have a military background, there are online military friendly colleges that provide tailored student support and flexible course delivery. These programs can help active-duty service members and veterans advance their education and prepare for civilian or research-based roles.

Careers related to molecular biology can also involve social and behavioral sciences. For example, an online masters of social work can lead to roles supporting public health, counseling, or community outreach. Similarly, pursuing a masters in psychology online can prepare you for roles in research, clinical practice, or education.

Consider your professional interests and personal needs when choosing an online degree pathway in molecular biology or a related field.

Best Scientists Citing Yuki Yamaguchi

Trending Scientists

Recently Published Articles